Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: December 15, 2003
Last updated: July 23, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):